Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 4, 2026
Optimizing transitions from direct factor Xa inhibitors to unfractionated heparin therapyMichael P Gulseth, Corey Dinunno, Marc D Smith, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 12, 2017
Successful use of laboratory monitoring to facilitate an invasive procedure for a patient treated with dabigatranMackenzie Byron, Sara Zochert, Thaddaus Hellwig, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 31, 2019
Use of specific anti-Xa levels in acute kidney injury to transition patients from oral factor Xa inhibitors to i.v. heparin infusionSara Zochert, Kiara M Oltman, Brittany M Elgersma, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 8, 2015
Relationship between time spent at extreme International Normalized Ratios and time in therapeutic range with bleeding and thrombosis in warfarin-treated patientsAshley L Barta, Edith A Nutescu, Paul A Thompson, et al.The Annals of Pharmacotherapy|May 2, 2022
Comparison of Managing Factor Xa Inhibitor to Unfractionated Heparin Transitions by aPTT Versus a Treatment Guideline Utilizing Heparin Anti-Xa LevelsScott J Dingus, Alex R Smith, William E Dager, et al.Pharmacotherapy|November 30, 2011
Dabigatran etexilate in clinical practice: confronting challenges to improve safety and effectivenessMichael P Gulseth, Ann K Wittkowsky, John Fanikos, et al.Pharmacotherapy|May 29, 2013
Rivaroxaban: practical considerations for ensuring safety and efficacyMaureen A Smythe, John Fanikos, Michael P Gulseth, et al.Pharmacotherapy|October 28, 2009
Key articles and guidelines in the treatment of venous thromboembolismPaul P Dobesh, Ann K Wittkowsky, Zachary Stacy, et al.Pageof 2